SHAPING THE OF PHARMACY
FUTURE
“Reading and studying about drug-related morbidity and mortality, pharmaceutical care, and practice transformation motivated me to change my own practice to focus on helping my patients achieve their therapeutic outcomes with safe and eff ective medications. I emphasized the need to become a pharmacist interventionist.”
Medication-Related Needs Indication Eff ectiveness Safety Adherence
(see attached SOAP note, pg. 16) We have been practicing this way since
2006. We regularly send our patient workups (SOAP notes) to prescribers. We identify MRPs, make clinical recommendations to resolve MRPs, and document our clinical activities. Because we consistently do this and our patient workups are regularly received by prescribers, this has become our standard of practice and is now expected by the prescribers. Utilizing this model of care has helped us achieve high performance on
Categories of MRPs
1. Unnecessary drug therapy 2. Needs additional therapy
3. Ineff ective drug 4. Dosage too low
5. Adverse drug reaction (includes side eff ects and drug interactions) 6. Dosage too high
7. Nonadherence
value-based contracts with payors. We have been able to increase our clinical revenue by 22-25% which has allowed our practice to thrive during a very diffi cult time in community pharmacy. We recognize the value we bring to the health care system and it’s all about us being interventionists!
THE LEADING VOICE FOR THE MISSOURI PHARMACIST |
MoRx.com 15
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
